Brief: Sprint Bioscience Appoints Mathias Skalmstad As Acting CEO
Dec 28 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* SPRINT BIOSCIENCE APPOINTS MATHIAS SKALMSTAD AS ACTING CEO
* BOD OF SPRINT BIOSCIENCE HAS TODAY APPOINTED CO'S CFO
MATHIAS
SKALMSTAD AS ACTING CEO AS OF JANUARY 23, 2023
* HE WILL TAKE OVER FROM CURRENT CEO ERIK KINNMAN
Source text for Eikon: ID:nMFN7fzdRY
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln